Skip to content
Clinical research for healthcare facilities

Clinical research: an opportunity for your hospital to grow

Within 10 working days you will know what the facility lacks for its first study — or for the next level, if studies are already running — and the order in which to close it. From there we bring the site to the state in which sponsors and CROs take it on.

What brings facilities to us

Three different situations, three different tasks

A facility with no experience, one with occasional protocols and one that is growing each run into something different. There is no single answer.

Outcome

What you will have

01

After 10 working days

A written conclusion: what in the facility already meets the requirements, what is missing — each point tied to a requirement — and the order in which to close it. The scope and cost of further work are known before any commitment.

02

Once the plan is implemented

Procedures the whole team works to. An ethics committee with its terms of reference and document control. Trained staff. A site profile — patient flow, indications, equipment, team — ready to send. Timing is set in the action plan.

03

In day-to-day work

A sponsor questionnaire is answered from the ready profile, not assembled department by department. The CROs that allocate protocols know the site. A new member of staff is working in weeks rather than months.

What it gives the facility

Four reasons to start

01

An additional source of funding

For running a study the facility is paid under its contract with the sponsor. The funds can go into equipment and development.

02

Reputation

An established research site increases confidence among peers, international partners and patients.

03

Clinical staff development

Working to international protocols develops clinicians, and helps attract good ones and keep them.

04

Modern treatment for patients

Patients reach innovative therapy before it is widely available. They stay with the facility, and they recommend it.

Market

The research market in Ukraine is active and changing

more than90
new research sites opened since 2023
more than60
of them opened by facilities with previous experience
more than30
opened by facilities entering clinical research for the first time

A first study rarely stays the only one

Of 30 facilities that entered clinical research for the first time since 2023, 18 have already received a second study, mostly within a year of the first. Those that started in 2023–2024 now have four on average.

New sites keep opening, and competition for studies is growing.

See the figures from the MoH register →

Who we work with

We work with facilities of every kind

Private

Private clinics

Unlocking the commercial side and building the processes international trials expect. An investment that can pay back on the first study, if recruitment holds up.

Municipal

Municipal and departmental hospitals

Patients get expensive drugs and investigations paid for by the study, and the hospital spends less of its own money. Extra funding without adding to the budget.

MoH / NAMS

Research institutes and Ministry of Health facilities

International protocols give an institute access to drugs and methods not yet in clinical practice, publications in international journals and a place in research networks — on the clinical base and staff it already has.

Services

How we help

You know where the facility stands

Readiness assessment across premises, equipment, pharmacy, laboratory, document control, ethics committee, SOPs and personnel. The output is a list of gaps, each tied to a requirement, and the order in which to close them.

The team works to one set of rules

A quality management system: SOPs, work instructions, policies and logs written for your facility. Processes stop depending on one person and are ready for sponsor monitoring and audit.

An ethics committee that does not hold up the start

Terms of reference, SOPs and document control for the ethics committee, so that study materials are reviewed in the facility under a clear procedure.

Everyone knows their role in a study

Staff training in ICH-GCP, study roles and the site’s own SOPs — with the training records a sponsor checks before the start.

Sponsors and CROs know the site

Site promotion: we build the site profile and present the facility, its sites and its investigator teams to sponsors and CROs, in Ukraine and abroad.

Decisions based on data

Market analytics: the state of clinical research nationally and in your region — who is nearby, in which indications, and which protocols you can realistically compete for.

A separate service

SMO support

The clinical side of the study remains with the facility. We take the operational side: coordination, documentation, interaction with the monitor, equipment readiness and the record of payable activity — the work that otherwise takes investigators’ time.

  • Running the study from feasibility and the site initiation visit through to close-out
  • A study coordinator on site — ours, or trained from your own staff
  • Source documents, CRFs and monitor queries answered within the agreed time
  • Recruitment logistics: screening, visit scheduling, handling of product and samples
  • Equipment control: verification, servicing, metrological compliance

A sponsor or a CRO? What we offer your side

How we work

From assessment to an operating site

Step 01

Current-state assessment

We look at where the facility starts from: building this up from scratch, or developing what already works — and what either takes. On site or remotely.

1–2 working days
Step 02

Report and action plan

A report on the current state of the facility and an action plan listing measures and deadlines.

up to 10 working days
Step 03

Plan and contract

What we do, in what order and by when is fixed in the contract before work starts.

as agreed
Step 04

Implementation

We put the procedures in place, train the team and send the site profile to CROs. After that, operational support for studies where needed.

timing set in the action plan
In more detail

Worth reading before we talk

First step

An assessment with no site visit and no commitment

Most of what has to be assessed can be covered from documents. Findings within 10 working days.

How it works
Method

What the report is based on

MoH Order No. 690, ICH E6, the rules on metrology and data protection, and findings from real inspections — so that the areas where sites most often fail are the ones examined.

How the assessment is built
For investigators

A stronger site means more studies

What established processes give the principal investigator and the team: more protocols and better sponsors, and where wanted, a site of their own.

The section for investigators
Our commitments

What we answer for

  • The conclusion within 10 working days.
  • Every finding tied to a specific requirement.
  • Scope and cost agreed before work starts.
  • A confidentiality agreement before the first document is shared.
  • The report belongs to the facility: you decide who sees it.

We do not promise a protocol: that is the sponsor’s decision, and it depends first of all on whether the right patients are there.

The questions we are asked most

Worth settling before we speak

All questions (12) →

Next step

Tell us about the facility and we will say where to start

A short call commits you to nothing. After it you will know the scope of the work and its cost, even if you decide to do everything in-house. We reply within one working day.

Prefer to call?
+38 (067) 495-08-80admin@meditext.com.ua
Mon–Fri, 09:00–18:00 (Kyiv time)